In CKD, elevated IL-8 is thought to reflect a uremia-driven inflammatory and vasculopathic milieu (47) rather than rejection-specific activation, whereas experimental data indicate that mitochondrial dysfunction and excessive mitochondrial ROS can further amplify IL-8 expression through NF-κB–dependent pathways (48). The gene discussed is NFKB1; the disease is uremia.